We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Some important facts about
A cardiac positron emission tomography with CT (PET/CT) scan images the heart muscle. Cardiac PET/CT provides improved accuracy, less radiation and increased efficiency in the detection of coronary artery disease compared to current modes of nuclear stress testing, such as single photon emission tomography (SPECT). Cardiac PET/CT is especially helpful in patients who have a high body mass index or have a large amount of breast/chest wall tissue, breast implants, or pleural or pericardial effusions.
Benefits of Cardiac PET/CT
Limiting Radiation Exposure
Diagnostic imaging is one of the sources and while these exams have led to significant improvements in detecting critical conditions, their use exposes patients to ionizing radiation, which may elevate one’s lifetime risk of cancer. Lowering patient exposure has thus developed into a key initiative for medical societies and regulatory agencies.
Myocardial Blood Flow (MBF) provides additional clinical information critical to the optimal use of Cardiac PET and PET/CT in patients with known or suspected CAD. MBF and Myocardial Flow Re-serve (MBFR) is now being implemented in clinics routinely for those who utilize Cardiac PET and PET/CT with Rubidium82 and is reimbursed by Medicare. MBF can be added to an existing Cardiac PET or PET/CT program relatively seamlessly. MIS provides a comprehensive approach, including MBF software selection, billing assistance, clinical education, and ongoing technical support. A key feature of our MBF Program is the peer-to-peer guidance anchored by noted cardiologist Gary V. Heller, MD, Ph.D.